ML21278B103: Difference between revisions

From kanterella
Jump to navigation Jump to search
(StriderTol Bot change)
(StriderTol Bot change)
 
(One intermediate revision by the same user not shown)
(No difference)

Latest revision as of 19:39, 19 November 2024

Transcript - Fda and NRC Workshop on Enhancing Development of Targeted Alpha-Emitting Radiopharmaceuticals, Special Session on Actinium-225
ML21278B103
Person / Time
Issue date: 09/22/2021
From:
NRC/NMSS/DMSST/MSEB
To:
Sarah Lopas
References
NRC-1654
Download: ML21278B103 (249)


Text